Perry P A
College of Nursing, Arizona State University, Tempe.
West J Nurs Res. 1995 Feb;17(1):63-75; discussion 101-11. doi: 10.1177/019394599501700106.
This study characterizes the response to dietary calcium in DOCA-salt hypertension. Body weight, systolic blood pressure, and total serum calcium levels were compared among normotensive control rats, DOCA-salt hypertensive rats treated with calcium carbonate (CaCO3) augmentation, and DOCA-salt hypertensive rats without supplementary dietary calcium. Dietary calcium augmentation prevented the rise of blood pressure that is normally produced by DOCA-salt. Attenuation in systolic blood pressure was independent of weight loss or total serum calcium and may be linked to alterations in calcium homeostasis that are seen in both human and experimental hypertension. Thus this study provides important data that may assist in further explicating the role that alterations in calcium homeostasis play in DOCA-salt hypertension. Further, these data may also be important in the identification of a nonpharmacological intervention for testing in humans.
本研究描述了去氧皮质酮盐性高血压对膳食钙的反应。对正常血压对照大鼠、用碳酸钙(CaCO₃)补充剂治疗的去氧皮质酮盐性高血压大鼠以及无膳食钙补充的去氧皮质酮盐性高血压大鼠的体重、收缩压和血清总钙水平进行了比较。膳食钙补充可预防去氧皮质酮盐通常引起的血压升高。收缩压的降低与体重减轻或血清总钙无关,可能与人类和实验性高血压中所见的钙稳态改变有关。因此,本研究提供了重要数据,可能有助于进一步阐明钙稳态改变在去氧皮质酮盐性高血压中所起的作用。此外,这些数据对于确定一种用于人体试验的非药物干预措施也可能很重要。